Metabolic Dysfunction-Associated Steatotic Liver Disease (NAFL)

Alias:
Non-Alcoholic Fatty Liver Disease
Fatty Liver
Nonalcoholic Fatty Liver Disease
Non-Alcoholic Fatty Liver
Nonalcoholic Steatohepatitis
Steatosis
Nafld
Non-Alcoholic Fatty Liver Disease Without Mention of Non-Alcoholic Steatohepatitis
Metabolic Dysfunction-Related Steatotic Liver Disease
Metabolic Dysfunction-Associated Fatty Liver Disease
Susceptibility to Nonalcoholic Fatty Liver Disease
Metabolic-Associated Fatty Liver Disease
Non-Alcoholic Steatohepatitis
Nafld Without Mention of Nash
Nonalcoholic Fatty Liver
Fatty Degeneration
Nafld Without Nash
Steatohepatitis
Mafld
Masld
Nafl
Nash
Favorite
基础信息
疾病表征
基因 & 突变
靶点药物
疾病模型
文献报道
代谢功能障碍相关性脂肪性肝病,也被称为非酒精性脂肪性肝病,与肝脏疾病和脂肪性肝病有关。与代谢功能障碍相关性脂肪性肝病相关的重要基因是MIR122(微小RNA 122),其相关通路/超级通路包括心肌细胞肥大中的微小RNA和参与DNA损伤反应的微小RNA。Entecavir和Simvastatin已在该疾病的背景下被提及。附属组织包括肝脏和骨骼肌。
Related ID:
MESH:D065626
ICD11:1912806631

Basic Information

Inheritance
Age of Onset
Prevalence
Related Gene
Related Mouse Models
Reference
MALACARDS
--
未知
--
58
654
3

Medical Symptom

#
Categorization
Description
HPO Frequency
Orphanet Frequency
HPO Source Accession
No data available

Gene & Mutation

#
Gene
Function
Score
Mutations
No data available

Related Drugs

Name
CAS Number
Status
Phase
No data available

Disease Model

Category
Name
MGI
Related Gene
Strain of Origin
Publications
No data available

References Literature

Title
PMID
Journal
Year
IF
No Data Found!
微信
信息比对
科研助手
使用教程
回到顶部